Ottobock stock reports 7.7 percent core revenue growth in H1 2026

Published on 10/06/2026 at 16:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ottobock stock delivered 7.7 percent core revenue growth in H1 2026, reaching EUR 818.5 million. Eight analysts set an average target of EUR 80.38.

Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock stock (ISIN DE000BCK2223) was last at EUR 50.20 on Xetra on October 5, 2026 at 5:35 p.m. CET, down 2.12 percent from the previous session. The companys latest operating figures show core business revenue of EUR 818.5 million in the first half of 2026, up 7.7 percent year over year, according to DrWeb on September 14, 2026.

Revenue growth reaches 7.7 percent

The H1 performance was driven by the core business, where adjusted EBITDA rose 18.1 percent to EUR 207 million. The adjusted EBITDA margin reached 25.3 percent, giving investors a more detailed profitability measure than revenue growth alone, DrWeb reported on September 14, 2026.

Ottobock operates in prosthetics, neuro-orthotics and exoskeletons and has more than 430 patient care centers in 45 countries. Its investor relations page also reports fiscal-year 2025 core revenue of EUR 350 million and adjusted EBITDA of EUR 90.04 million, with growth of 11.7 percent and 29.5 percent respectively, Ottobock states.

Analysts see higher valuation

Jefferies kept Ottobock at Buy with a EUR 83 target on September 15, 2026, unchanged from its previous target, while Berenberg maintained Hold and a EUR 66 target on September 11, 2026, according to MarketScreener.

The published consensus is Buy from eight analysts, with an average target of EUR 80.38. Against the EUR 50.20 Xetra price on October 5, 2026, that target stands 60.12 percent above the stock, a gap that reflects the difference between improved operating momentum and a share price still below recent analyst valuations, according to MarketScreener.

Q3 report is scheduled for November

Ottobock has scheduled publication of its Q3 2026 quarterly statement for November 12, 2026, according to the companys investor calendar, Ottobock lists. The date gives the next concrete checkpoint for testing whether the 7.7 percent H1 core revenue growth and 25.3 percent adjusted EBITDA margin extend into the second half.

Ottobock stock trades below analyst targets

On October 5, 2026, the Xetra price was EUR 50.20 and the daily change was minus 2.12 percent, with 20,088 shares traded. The combination of rising H1 profitability, a Buy consensus and a lower market price leaves the Q3 report as the next measurable test for the stock.